"Through HIV multiplication, [we] selected a "library" of nearly 80 mutant proteins and tested them on tumor cells in the presence of an anticancer drug. The results have enabled us identify a dCK variant that is more effective than the wild-type (non-mutated) protein, inducing the death of tumor cells in culture," said the researchers in a statement, reported Counsel and Heal.

"The possibility of reducing the doses of anticancer drugs would palliate the problems posed by their components' toxicity, reduce their side-effects and, most importantly, improve their effectiveness."

The work we do has never been more important — whether it’s because of “news” that might not be news at all or healing the deep divides in our country. Now more than ever, we need conversation, perspective and diverse voices. Will you support PRI in our efforts to create a more informed empathetic world?